- Home
- INDI vs BBNX Comparison
INDI vs BBNX Comparison
Compare INDI & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- BBNX
- Stock Information
- Founded
- INDI 2007
- BBNX 2015
- Country
- INDI United States
- BBNX United States
- Employees
- INDI N/A
- BBNX N/A
- Industry
- INDI Semiconductors
- BBNX Medical/Dental Instruments
- Sector
- INDI Technology
- BBNX Health Care
- Exchange
- INDI Nasdaq
- BBNX Nasdaq
- Market Cap
- INDI 610.0M
- BBNX 649.9M
- IPO Year
- INDI N/A
- BBNX 2025
- Fundamental
- Price
- INDI $3.82
- BBNX $12.67
- Analyst Decision
- INDI Strong Buy
- BBNX Strong Buy
- Analyst Count
- INDI 6
- BBNX 10
- Target Price
- INDI $6.08
- BBNX $25.20
- AVG Volume (30 Days)
- INDI 4.4M
- BBNX 467.2K
- Earning Date
- INDI 08-07-2025
- BBNX 07-29-2025
- Dividend Yield
- INDI N/A
- BBNX N/A
- EPS Growth
- INDI N/A
- BBNX N/A
- EPS
- INDI N/A
- BBNX N/A
- Revenue
- INDI $218,406,000.00
- BBNX $69,830,000.00
- Revenue This Year
- INDI $7.46
- BBNX $32.79
- Revenue Next Year
- INDI $32.80
- BBNX $36.59
- P/E Ratio
- INDI N/A
- BBNX N/A
- Revenue Growth
- INDI N/A
- BBNX 38911.17
- 52 Week Low
- INDI $1.53
- BBNX $8.89
- 52 Week High
- INDI $7.45
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- INDI 63.01
- BBNX N/A
- Support Level
- INDI $3.50
- BBNX N/A
- Resistance Level
- INDI $4.08
- BBNX N/A
- Average True Range (ATR)
- INDI 0.31
- BBNX 0.00
- MACD
- INDI -0.00
- BBNX 0.00
- Stochastic Oscillator
- INDI 72.12
- BBNX 0.00
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for advanced Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.